Date | Title | Description | Source |
24.04.2024 | Prevent Blindness Declares May as First-ever Inherited Retin... | Prevent Blindness declares the month of May as "Inherited Retinal Disease Genetic Testing Aware... | prweb.com/... |
17.04.2024 | World Hemophilia Day 2024"Equitable access for all: rec... | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community ... | en.prnasia... |
09.05.2023 | Prevent Blindness Declares Fourth Annual Inherited Retinal D... | Prevent Blindness declares May 15-21, 2023, as the 4th annual “Inherited Retinal Disease (IRD) Genet... | prweb.com/... |
11.05.2022 | Prevent Blindness Declares Third Annual Inherited Retinal Di... | To help save sight, Prevent Blindness declares May 16-22 as the Third Annual Inherited Retinal Disea... | prweb.com/... |
10.05.2022 | The POWER of Professional Women Honors Allies for Women in B... | Executive leaders from Day & Zimmermann and Santander Bank, N.A. will be recognized for their ad... | einpresswi... |
12.10.2021 | Spark Therapeutics and CombiGene Enter into Exclusive, Globa... | PHILADELPHIA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX... | globenewsw... |
14.05.2021 | Prevent Blindness Declares Second Annual Inherited Retinal D... | Prevent Blindness declares May 16-22, 2021, as it's second annual “Inherited Retinal Disease (IRD) G... | prweb.com/... |
30.11.2020 | Navigating the challenge of covering breakthrough therapies ... | Our virtual MedCity INVEST Precision Medicine conference, December 9-11, will highlight aspects of p... | medcitynew... |
24.11.2020 | Mark your calendars for our virtual INVEST Precision Medicin... | What Does the Diagnostics Landscape Look Like?
Diagnostics is joined at the hip with precision medic... | medcitynew... |
16.05.2019 | Installment payments could be used across gene therapy space... | “Certainly, we are continuously optimistic, but we would like to see the pace of policy changes we w... | medcitynew... |
29.04.2019 | Report: Takeda adopts value-based pricing for Crohn’s stem c... | Despite winning EMA approval for complex perianal fistulas in Crohn’s more than a year ago, Alofisel... | medcitynew... |
25.02.2019 | Term Sheet — Monday, February 25 | TECH INTIMACY
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundar... | fortune.co... |
25.02.2019 | Spark Therapeutics enters into definitive merger agreement w... | Roche to acquire Spark Therapeutics for $114.50 per share representing a total equity value of $4.8 ... | 4biocapita... |
19.12.2018 | Developing a new gene therapy was hard. So was figuring out ... | After a career spent in pharmaceutical commercial strategy and operations, I thought I had a handle ... | statnews.c... |
27.11.2018 | Spark, Novartis’s inherited blindness therapy Luxturna wins ... | Luxturna is a viral vector-based gene therapy that uses an adeno-associated viral vector to provide ... | medcitynew... |
21.09.2018 | Novartis, Spark make positive step toward gene therapy Luxtu... | Under an agreement between the two companies, Novartis is marketing Luxturna in markets outside the ... | medcitynew... |
08.05.2018 | Atara enlists Juno co-founder Michel Sadelain in CAR-T ef... | Michel Sadelain
→ The day after Atara announced that it is bringing Genentech vet Dietmar Ber... | endpts.com... |
03.05.2018 | How much would you pay for the miracle of gene therapy? | Every day I wake up thinking about how to get gene therapy to the children who will benefit from thi... | statnews.c... |
03.01.2018 | Spark Therapeutics Announces Pricing and First-of-their-kind... | | 4biocapita... |
20.12.2017 | Spark Therapeutics’ new FDA approval shows gene therapies ar... | It’s a historic moment for many in the industry, including FDA Commissioner Scott Gottlieb who has o... | medcitynew... |
19.12.2017 | FDA Approves Spark Therapeutics’ LUXTURNA™ (voretigene nepar... | Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging t... | 4biocapita... |
30.10.2017 | Gene editing remains early stage, but Big Pharma has taken n... | In its recent report, titled Gene Editing: The Next Breakthrough in Regenerative Medicine, Informa P... | medcitynew... |
20.09.2017 | The Biotech Devil’s Dictionary: Your guide to the inanities ... | Biotech can be a breeding ground for jargon, coded language, and outright nonsense, as investors and... | statnews.c... |
29.06.2017 | What’s Militia Hill Ventures’ take on biotech, cancer therap... | What informs your investment strategy for Militia Ventures?
At Militia Hill Ventures, we build biote... | medcitynew... |
10.05.2017 | Pfizer and Sangamo ink a $545M hemophilia-gene therapy deal | In return for global commercialization rights, Pfizer will pay $70 million upfront and up to $475 mi... | medcitynew... |
05.12.2016 | Can Alnylam rise from the ASHes? | Now in San Diego, California, for the 58th American Society of Hematology (ASH) meeting, Alnylam des... | medcitynew... |
26.08.2016 | Sofinnova Ventures has raised $595M for its largest fund to ... | The company’s strategy of investing in late-stage private companies has found some receptive buyers ... | medcitynew... |
29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
15.06.2016 | Hemophilia ‘cures’ are proving gene therapy really is all it... | Gene therapy is part of an increasingly large collection of research fields: those with a huge, usel... | extremetec... |
08.03.2016 | Genable Technologies Investors Secure Spark Exit | Venture capital investors in TCD campus company Genable Technologies have secured an exit from the l... | businesspl... |
19.05.2015 | Sidecar wins Tech Startup of the Year at PACT’s Enterprise A... | Sidecar, the Center City digital marketing startup, won PACT’s Enterprise Award for Startup Technolo... | technical.... |
28.11.2014 | Spark Therapeutics adds regulatory insider to support gene t... | Romuald Corbau, former research project leader for Pfizer’s gene therapy program for the hepatitis C... | medcitynew... |
10.07.2014 | Sofinnova appears to be bulking up a healthcare venture fund... | Sofinnova Ventures has a robust active portfolio. Some of its more notable funding rounds include pa... | medcitynew... |
10.07.2014 | Venture-backed healthcare deals rise to $2.7B in Q2 | States accounting for the most deal activity Although Pennsylvania has a thriving biotechnology and ... | medcitynew... |
04.06.2014 | Sidecar raises $3.1M; Spark Therapeutics raises $72.8M [Star... | WHO’S GETTING FUNDED?
Sidecar, the Center City ecommerce marketing company, raised $3.1 million in a... | technical.... |
28.05.2014 | Spark Therapeutics Raises $72.8M |
PHILADELPHIA, PA, Late-stage company developing gene-based medicines for a wide range of rare, deb... | vcnewsdail... |
27.05.2014 | Spark Therapeutics Completes $72.8M Series B Financing | Spark Therapeutics, a Philadelphia, PA-based late-stage company developing gene-based medicines for ... | finsmes.co... |
27.05.2014 | Spark Therapeutics’ late-stage gene therapy for inherited bl... | Developed at CHOP’s Center for Cellular and Molecular Therapeutics, the therapy uses a neutralized v... | medcitynew... |
25.03.2014 | Gene therapy company Spark Therapeutics inks licensing deal ... | Rhodopsin-linked autosomal dominant retinitis pigmentosa affects roughly 30,000 people worldwide and... | medcitynew... |
15.01.2014 | Sidecar raises $1M from local investors like Michael Rubin [... | WHO’S GETTING FUNDED?
Rick Nucci‘s stealth mode startup, Guru Technologies, has raised $2.7 million ... | technical.... |
11.12.2013 | Apprennet awarded $150K Science Foundation grant [Startup Ro... | WHO’S GETTING FUNDED?
Apprennet, an online learning startup, was awarded a $150,000 National Science... | technical.... |
20.11.2013 | Gene therapy startup launches with $5M and eyes toward a bet... | Currently Dimension is working on IND-enabling studies of a drug candidate for hemophilia B, a hered... | medcitynew... |
- | Spark Therapeutics’ late-stage gene therapy for inherited bl... | A Children’s Hospital of Philadelphia spinout with the potential to be the first to win U.S. FDA app... | medcitynew... |
- | Venture-backed healthcare deals rise to $2.7B in Q2 | About $13.88 billion in venture capital backed 974 deals in the second quarter, the highest level si... | medcitynew... |
- | Report: Takeda adopts value-based pricing for Crohn’s stem c... | A Japanese drugmaker is using value-based pricing in Europe for an expensive cell therapy used to tr... | medcitynew... |
- | Genome editing and Personalized Medicine: What it is (and wh... | BURLINGTON, Mass. — When the first sequencing of a human genome was announced in 2003, a coalition o... | statnews.c... |
- | Sofinnova Ventures has raised $595M for its largest fund to ... | Life sciences investor Sofinnova Ventures is raising fund number 10 in what, as FierceBiotech notes,... | medcitynew... |
- | Mark your calendars for our virtual INVEST Precision Medicin... | The vision of precision medicine is to enable doctors, researchers and others to more accurately pre... | medcitynew... |
- | A biotech CEO plans to charge up to $3 million for a gene th... | Jean-Jacques Bienaimé, the CEO of BioMarin Pharmaceutical. BioMarin Pharmaceutical This story is ava... | businessin... |
- | Gene therapy company Spark Therapeutics inks licensing deal ... | Retinitis pigmentosa is the most common inherited eye disease. Mutations in the gene for rhodopsin, ... | medcitynew... |
- | Navigating the challenge of covering breakthrough therapies ... | Our virtual MedCity INVEST Precision Medicine conference, December 9-11, will highlight aspects of p... | medcitynew... |
- | Sofinnova appears to be bulking up a healthcare venture fund... | Looks like Sofinnova Ventures is bulking up one of its venture funds – up from $50 million a year ag... | medcitynew... |
- | Spark, Novartis’s inherited blindness therapy Luxturna wins ... | A gene therapy that was the first of its kind to receive Food and Drug Approval in the US has won ap... | medcitynew... |
- | Spark Therapeutics’ new FDA approval shows gene therapies ar... | It didn’t happen overnight, but gene therapy has officially arrived.
On Tuesday morning, the U.S. Fo... | medcitynew... |
- | Can Alnylam rise from the ASHes? | October was a bad month for Alnylam. Its shares plunged almost 50 percent after it abruptly scrapped... | medcitynew... |
- | Novartis, Spark make positive step toward gene therapy Luxtu... | The first gene therapy approved in the United States made a significant step toward winning approval... | medcitynew... |
- | Pfizer and Sangamo ink a $545M hemophilia-gene therapy deal | Sangamo Therapeutics has lofty aims for its gene therapy programs — but at least one Big Pharma comp... | medcitynew... |
- | Gene editing remains early stage, but Big Pharma has taken n... | The field of gene editing is moving fast. In late October, two new papers described technologies tha... | medcitynew... |
- | ‘That’s $425,000 right there’ — the anxious launch of a gene... | BOSTON — The trouble had started over a decade ago, when the Hogans noticed something wasn’t right w... | statnews.c... |
- | Installment payments could be used across gene therapy space... | Payments over time are an attractive model for paying for expensive gene therapies, but things need ... | medcitynew... |
- | Spark Therapeutics adds regulatory insider to support gene t... | A gene therapy spinout from Children’s Hospital of Philadelphia has added a head of regulatory affai... | medcitynew... |
- | Gene therapy startup launches with $5M and eyes toward a bet... | A newly formed gene therapy startup is taking gene delivery technology from ReGenX and a $5 million ... | medcitynew... |
- | What’s Militia Hill Ventures’ take on biotech, cancer therap... | Jane Holmes Hollingsworth is a Philadelphia-based serial healthcare entrepreneur with a couple of su... | medcitynew... |
- | Kids with 'bubble boy' disease are dying — even though drug ... | This story is available exclusively to Insider subscribers. Become an Insider and start reading now.... | businessin... |